HIV 'magic pill' continues despite side effects

When briefing the Parliament last week Friday, the assistant minister of Health and Wellness Biggie Butale said that the concern that Dolutegravier may be causing birth defects involving brain and spine (Neural Tubal Defects-NTD) is not yet confirmed, therefore there are no plans to end the use of the drug.

He was answering a question from the Member of Parliament of Tlokweng Kenneth Segokgo, who wanted to know if the Ministry intended terminating the use of DTG with reports of some women on DTG regimen, giving birth to babies with NTD.